A message from American Alternative We printed 1,000 copies of this report. 688 are gone. When the last one goes out, we're pulling it offline — the information inside is too sensitive to leave up indefinitely. Here's what's inside the remaining copies: The executive order Trump can sign tomorrow — the same legal authority FDR used in 1934 to move billions in wealth overnight — and exactly how to position before it happens. This isn't a newsletter. It's not evergreen content. It's a window. And 688 people already jumped through it. Claim one of the 312 remaining copies → We won't reopen this once it's closed. Get my copy now →
Featured News from MarketBeat 3 Blue-Chip Stocks Built for a Rotating MarketBy Chris Markoch. First Published: 3/8/2026. 
Key Points - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
- Special Report: Get "backdoor access" BEFORE the SpaceX IPO
 Sector rotation occurs when investors move money out of market sectors that look overbought and into ones that seem undervalued. In 2026, that has mostly meant rotating away from mega-cap technology names and into value-oriented, defensive sectors such as energy and consumer staples. The key word is overvalued. Big Tech has been running hot for more than two years, driven largely by excitement around artificial intelligence (AI). Despite concerns about a repeat of the dot-com era, many investors largely ignored the lofty valuations of these stocks. When a company like SpaceX is about to go public, the insiders always get first dibs—Goldman Sachs, Morgan Stanley, the hedge fund managers, the billionaires load up on shares at rock-bottom prices, then open the doors to regular investors after the biggest gains are already locked in. But Dr. Mark Skousen just found a crack in the system—a backdoor that lets you grab a pre-IPO stake in SpaceX before Elon makes the trillion-dollar announcement. Inside this special presentation, you'll also learn how you can stake a claim in one of the most concentrated SpaceX holdings we know of. Click here for your free SpaceX ticker But investors who believed this time was different are discovering that valuation doesn't matter until it does. As the economy warms, investors are hunting for value elsewhere — including blue-chip defensive names like the ones profiled below. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. The utility is a major provider in the Southeast and Midwest United States, and utilities stocks are traditionally viewed as defensive, value-oriented income plays. Duke offers a dividend that yields around 3.2%, and the company has increased its payout for 20 consecutive years. The shifting U.S. energy landscape is also opening opportunities for growth at DUK. The company follows an "all of the above" approach to generation — including nuclear, hydroelectric and natural gas. Strength in natural gas has helped fuel the stock's strong bounce in 2026. But Duke's steady revenue base from its residential utility business, combined with projected growth in areas such as data centers, is what makes DUK a sector-rotation target. DUK is up nearly 12% year to date in 2026, putting it within about 5% of the consensus price target of $136.87, which would push the stock above its 52-week high. Trading around 20.5x earnings, the stock sits at a slight premium to its historical average. Since the company reported earnings in February, analysts have been raising price targets amid expectations for strong year-over-year revenue growth in the second half of the year — a development that could prompt a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts expect biotechnology to benefit as rotation continues, and Gilead Sciences (NASDAQ: GILD) offers defensive growth within the healthcare sector, which has generally lagged the broader market. Gilead is a leading provider of HIV therapies, with key drugs that retain patent protection into the 2030s. Investors are also encouraged by a pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026 and may secure a label expansion for its breast cancer drug, Trodelvy. GILD is up nearly 18% in 2026 and reached a 52-week high earlier this year. The modest pullback since then likely reflects some profit-taking after an outsized run-up, which could create a buy-the-dip opportunity. Analysts carry a consensus price target of $156.72 on GILD, implying upside of more than 8%. Since the February earnings report, many analysts have nudged estimates higher, with the most bullish target around $170. Gilead also pays a reliable dividend, yielding roughly 2.28%, and has increased its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) has been one of the clearest beneficiaries of the 2026 rotation into consumer staples stocks. HSY is up nearly 25% year to date and has broken out of the bearish trend it carried since 2023. The company faced headwinds from higher cocoa prices through 2025, and those costs will still weigh on earnings in 2026. But the market looks forward, and analysts are forecasting stronger earnings and revenue growth later this year. HSY is trading above its consensus price target of $222.21, yet analysts have been lifting targets since the February report. The most bullish call comes from Goldman Sachs, which has a $267 target. In that earnings report, Hershey raised its dividend by 5.9%, marking 15 consecutive years of increases. The stock yields roughly 2.5% and has an annual payout of $5.81 per share. Following the recent rally, HSY trades above 50x earnings — a valuation level that likely triggered heavy institutional selling last quarter. For long-term investors, that pullback could present another chance to add a share of this well-known consumer name. | 
0 Response to "The window is closing"
Post a Comment